FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W190767888> ?p ?o ?g. }

• W190767888 endingPage "992" @default.
• W190767888 startingPage "987" @default.
• W190767888 abstract "Chronic hepatitis C virus (HCV) infection is frequent among HIV-infected patients. Clearance of serum HCV RNA 6 months after discontinuing HCV therapy is generally interpreted as a cure of HCV infection in HIV-negative subjects. However, the occurrence of liver complications (including hepatocellular carcinoma) and/or HCV relapses in coinfected patients when followed for long periods of time after HCV therapy is not well known.All HIV-infected patients who had been treated for chronic hepatitis C at our institution and had a minimum follow-up of 6 months after discontinuing therapy were retrospectively analysed. They had received one of three HCV treatment modalities: IFN monotherapy, IFN plus ribavirin (RBV) or pegylated interferon (PEG-IFN) plus RBV.A total of 351 patients were retrospectively analysed. Sustained virological response (SVR) to HCV therapy had been reached by 77 (22%) of them: 22/119 (18.5%) with IFN monotherapy, 17/106 (16%) with IFN plus RBV and 38/126 (30.2%) with PEG-IFN plus RBV. Considering the HCV genotypes, SVR had been reached by 19/184 (10.3%) of patients with genotype 1, 54/138 (39.1%) with genotypes 2 or 3, and 4/29 (13.8%) of those with genotype 4. Within a total of 4466 patient-months follow-up (mean of 58 months), none of the 77 patients with SVR showed HCV-RNA rebounds, elevations in liver enzymes potentially linked to HCV, development of hepatocellular carcinoma or episodes of decompensated cirrhosis. In contrast, all 274 patients who did not reach SVR with HCV therapy showed evidence of persistent serum HCV RNA and 90% of them showed liver enzyme elevations during a total of 15344 patient-months follow-up (mean of 56 months). Moreover, 11 (4%) developed clinical complications of liver cirrhosis and two of them died of end-stage liver disease.HCV replication and HCV-related liver disease seem to be permanently halted in HIV/HCV-coinfected patients showing HCV-RNA clearance 6 months after completing any kind of IFN-based therapy. In contrast, complications of liver disease due to persistent HCV infection continue to occur in non-responders. The role of maintenance HCV therapy should be explored in HIV/HCV-coinfected patients." @default.
• W190767888 created "2016-06-24" @default.
• W190767888 creator A5003553956 @default.
• W190767888 creator A5040857112 @default.
• W190767888 creator A5049419930 @default.
• W190767888 creator A5058909267 @default.
• W190767888 creator A5074827235 @default.
• W190767888 creator A5075118902 @default.
• W190767888 creator A5075493481 @default.
• W190767888 date "2004-08-01" @default.
• W190767888 modified "2023-10-18" @default.
• W190767888 title "Long-Term Follow-Up of HIV-Infected Patients with Chronic Hepatitis C Virus Infection Treated with Interferon-Based Therapies" @default.
• W190767888 cites W1967982404 @default.
• W190767888 cites W1983551473 @default.
• W190767888 cites W1987268569 @default.
• W190767888 cites W1993484328 @default.
• W190767888 cites W1996434966 @default.
• W190767888 cites W2000674705 @default.
• W190767888 cites W2004602615 @default.
• W190767888 cites W2005933189 @default.
• W190767888 cites W2006597120 @default.
• W190767888 cites W2015199158 @default.
• W190767888 cites W2021435909 @default.
• W190767888 cites W2025981613 @default.
• W190767888 cites W2034000389 @default.
• W190767888 cites W2060483294 @default.
• W190767888 cites W2065213172 @default.
• W190767888 cites W2070274890 @default.
• W190767888 cites W2070310839 @default.
• W190767888 cites W2075365109 @default.
• W190767888 cites W2075560005 @default.
• W190767888 cites W2080883339 @default.
• W190767888 cites W2082990787 @default.
• W190767888 cites W2083997028 @default.
• W190767888 cites W2087389370 @default.
• W190767888 cites W2094883696 @default.
• W190767888 cites W2100229458 @default.
• W190767888 cites W2103529803 @default.
• W190767888 cites W2118108577 @default.
• W190767888 cites W2133580842 @default.
• W190767888 cites W2141228361 @default.
• W190767888 cites W2145920352 @default.
• W190767888 cites W2157998939 @default.
• W190767888 cites W2328455729 @default.
• W190767888 cites W4243503422 @default.
• W190767888 doi "https://doi.org/10.1177/135965350400900616" @default.
• W190767888 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15651757" @default.
• W190767888 hasPublicationYear "2004" @default.
• W190767888 type Work @default.
• W190767888 sameAs 190767888 @default.
• W190767888 citedByCount "52" @default.
• W190767888 countsByYear W1907678882012 @default.
• W190767888 countsByYear W1907678882013 @default.
• W190767888 countsByYear W1907678882014 @default.
• W190767888 countsByYear W1907678882015 @default.
• W190767888 countsByYear W1907678882016 @default.
• W190767888 countsByYear W1907678882021 @default.
• W190767888 countsByYear W1907678882022 @default.
• W190767888 crossrefType "journal-article" @default.
• W190767888 hasAuthorship W190767888A5003553956 @default.
• W190767888 hasAuthorship W190767888A5040857112 @default.
• W190767888 hasAuthorship W190767888A5049419930 @default.
• W190767888 hasAuthorship W190767888A5058909267 @default.
• W190767888 hasAuthorship W190767888A5074827235 @default.
• W190767888 hasAuthorship W190767888A5075118902 @default.
• W190767888 hasAuthorship W190767888A5075493481 @default.
• W190767888 hasBestOaLocation W1907678881 @default.
• W190767888 hasConcept C126322002 @default.
• W190767888 hasConcept C203014093 @default.
• W190767888 hasConcept C2522874641 @default.
• W190767888 hasConcept C2776408679 @default.
• W190767888 hasConcept C2776455275 @default.
• W190767888 hasConcept C2776461080 @default.
• W190767888 hasConcept C2777214474 @default.
• W190767888 hasConcept C2778019345 @default.
• W190767888 hasConcept C2780040827 @default.
• W190767888 hasConcept C71924100 @default.
• W190767888 hasConcept C90924648 @default.
• W190767888 hasConceptScore W190767888C126322002 @default.
• W190767888 hasConceptScore W190767888C203014093 @default.
• W190767888 hasConceptScore W190767888C2522874641 @default.
• W190767888 hasConceptScore W190767888C2776408679 @default.
• W190767888 hasConceptScore W190767888C2776455275 @default.
• W190767888 hasConceptScore W190767888C2776461080 @default.
• W190767888 hasConceptScore W190767888C2777214474 @default.
• W190767888 hasConceptScore W190767888C2778019345 @default.
• W190767888 hasConceptScore W190767888C2780040827 @default.
• W190767888 hasConceptScore W190767888C71924100 @default.
• W190767888 hasConceptScore W190767888C90924648 @default.
• W190767888 hasIssue "6" @default.
• W190767888 hasLocation W1907678881 @default.
• W190767888 hasLocation W1907678882 @default.
• W190767888 hasOpenAccess W190767888 @default.
• W190767888 hasPrimaryLocation W1907678881 @default.
• W190767888 hasRelatedWork W1982541345 @default.
• W190767888 hasRelatedWork W2008626862 @default.
• W190767888 hasRelatedWork W2008996336 @default.
• W190767888 hasRelatedWork W2011122771 @default.

• next